Doxorubicin Hydrochloride Injectable, Liposomal (Zydus) Updated

27 Mar 20264 min read0 viewsVerified Feed

GIST

DailyMed Drug Label Updates published a clinical update in Pharmacology on 27 Mar 2026. The item focuses on DOXORUBICIN HYDROCHLORIDE injectable, liposomal [Zydus Pharmaceuticals USA Inc.]. Review the original article for the full source wording and details.

Clinical Editorial

Summary

DailyMed Drug Label Updates published a clinical update in Pharmacology on 27 Mar 2026.

The item focuses on DOXORUBICIN HYDROCHLORIDE injectable, liposomal [Zydus Pharmaceuticals USA Inc.].

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Br J CancerRelated by Drugdoxorubicin

Phase Ib Trial of SL-172154 With Mirvetuximab Soravtansine or Pegylated Liposomal Doxorubicin in

Oncology • 08 Apr 2026

JAHARelated by Drugdoxorubicin

Sympathetic Overdrive, Vascular Dysfunction, and Exercise Intolerance in Long-Term Breast Cancer

Cardiology • 13 Mar 2026

Feed Metadata

Source

DailyMed Drug Label Updates